US 10,428,117 B2Granted

Piscine myocarditis virus-like particles and methods of use thereof

AssigneePharmaq AS

InventorsPal Nilsen, Marit Rode

Life of this patent

Estimating the term…

Abstract

The present invention relates to a piscine myocarditis virus (PMCV) virus-like particle (VLP) which consists only of PMCV ORF1 protein.

Claims9

Dependent claims

A vaccine composition comprising a recombinant piscine myocarditis virus (PMCV) virus-like particle (VLP) comprising a PMCV ORF1 protein comprising SEQ ID NO.2.

Dependencies are inferred from the claim text.

Facts

Application: 15/883,202Filed 30 Jan 2018
Priority: GB 1701573.631 Jan 2017
Published: US 2018/0215793 A12 Aug 2018
Granted: 1 Oct 2019
Term ends: Not estimatedThe source records don’t support an estimate.

Classification15 codes

C07K 14/005
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: from viruses
A61K 39/12
Medicinal preparations containing antigens or antibodies: viral antigens
C12N 7/00
Viruses
C12N 15/85
Vectors or expression systems specially adapted for eukaryotic hosts: for animal cells

Family

US 2018/0215793 A1Pre-grant publication · published 2 Aug 2018
US 10,428,117 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results